Terms: = Ovarian cancer AND TCF3, E2A, 6929, ENSG00000071564, P15923, MGC129648, MGC129647, ITF1
4 results:
1. Long-Term Survival Among Histological Subtypes in Advanced Epithelial ovarian cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database.
Yang SP; Su HL; Chen XB; Hua L; Chen JX; Hu M; Lei J; Wu SG; Zhou J
JMIR Public Health Surveill; 2021 Nov; 7(11):e25976. PubMed ID: 34787583
[TBL] [Abstract] [Full Text] [Related]
2. Disease-inducing potential of two leukemic cell lines in a xenografting model.
Manavella DD; Herraiz S; Soares M; Buigues A; Pellicer A; Donnez J; Díaz-García C; Dolmans MM
J Assist Reprod Genet; 2021 Jun; 38(6):1589-1600. PubMed ID: 33786735
[TBL] [Abstract] [Full Text] [Related]
3. Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.
Ricci F; Fratelli M; Guffanti F; Porcu L; Spriano F; Dell'Anna T; Fruscio R; Damia G
Oncotarget; 2017 Jan; 8(5):7441-7451. PubMed ID: 26910918
[TBL] [Abstract] [Full Text] [Related]
4. Mapping of the 19p13 breakpoint in an ovarian carcinoma between the INSR and tcf3 loci.
Aman P; Pejovic T; Wennborg A; Heim S; Mitelman F
Genes Chromosomes Cancer; 1993 Oct; 8(2):134-6. PubMed ID: 7504518
[TBL] [Abstract] [Full Text] [Related]
